TB Vaccine Pipeline

TB Vaccines Pipeline

  • Viral Vector
  • Protein/Adjuvant
  • Mycobacterial – Killed Whole Cell or Extract
  • Mycobacterial – Live Attenuated

Self-reported by vaccine sponsors; revised 25 September 2017
Image courtesy of Aeras

Phase 1
MTBVAC

Biofabri, TBVI, Zaragosa

Ad5 Ag85A

McMaster, CanSino

ChAdOx185A/MVA85A (ID/IM/Aerosol)

Univ of Oxford

Phase 2a
RUTI

Archivel Farma, S.L

H1/H56: IC31

SSI, Valneva, Aeras

H4: IC31

Sanofi Pasteur, SSI, Aeras

ID93 + GLA-SE

IDRI, Wellcome Trust

TB/FLU-04L

RIBSP

Phase 2b
DAR-901

Dartmouth, GHIT

M72 + AS01E

GSK, Aeras

Phase 3
Vaccae

Anhui Zhifei Longcom

VPM1002

SII, Max Planck, VPM, TBVI
(Phase 2/3)

The WGNV is in the process of updating the pipeline of candidates in earlier stages of development. To submit a vaccine candidate for inclusion in this upcoming pipeline, please contact us.

 

Get Involved

If you would like to learn more about the WGNV and how you can be, please contact us!

Contact Us